Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:07 AM
Ignite Modification Date:
2025-12-25 @ 3:07 AM
NCT ID:
NCT05819333
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of stroke
* Greater than 6 months post-stroke
* Signed letter of medical approval from primary care physician to participate in this research study
* Community dwelling
* Ability to attend the wellness program 3x/week for eight weeks
* Ability to follow instructions or mimic exercises
* Ability to communicate adverse effects such as pain or fatigue or the need for assistance
* Able to ambulate 20 feet with no more than contact guard assist, with or without an assistive device or orthotic device
* Able to access exercise equipment independently or with caregiver assist
* Greater than 18 years of age
Exclusion Criteria:
* Neurologic condition other than stroke, i.e. Parkinson's Disease, multiple sclerosis
* Severe, functional limiting arthritis
* Orthopedic condition that limits mobility
* Severe weight-bearing pain
* Current participation in other physical rehabilitation services or exercise programs
* Serious cardiac conditions (hospitalization for myocardial infarction or heart surgery within the past year, history of congestive heart failure, documented serious and unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during activities of daily living). Anyone meeting New York Heart Association criteria for Class 3 or Class 4 heart disease will be excluded
* Severe hypertension: with systolic \> 200 mmHg and diastolic \> 110 mmHg at rest, that cannot be medically controlled into the resting range of 180/100 mmHg
* Use of supplemental oxygen at baseline
* Severe obstructive pulmonary disease (Classification of Global Initiative for Chronic Obstructive Lung Disease (GOLD)39 3 or higher, indicating FEV1\<50% predicted)
* Treatment for pneumonia or lower respiratory infection within the past month
* Able to run one-quarter mile without stopping
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
95 Years
Study:
NCT05819333
Study Brief:
Protocol Section:
NCT05819333